Английская Википедия:Indium (111In) capromab pendetide

Материал из Онлайн справочника
Версия от 22:50, 25 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{DISPLAYTITLE:Indium (<sup>111</sup>In) capromab pendetide}} {{Drugbox | Verifiedfields = changed | verifiedrevid = 458271478 | image = | drug_name = Indium (<sup>111</sup>In) capromab pendetide <!-- Monoclonal antibody data --> | type = mab | mab_type = mab | source = o | target = Glutamate carboxypeptidase II <!-- Clinical data --> | tradename = Prostascint | pregnancy_AU =...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Drugbox

Indium (111In) capromab pendetide (trade name Prostascint) is used to image the extent of prostate cancer.[1] Capromab is a mouse monoclonal antibody which recognizes a protein found on both prostate cancer cells and normal prostate tissue. It is linked to pendetide, a derivative of DTPA.[2] Pendetide acts as a chelating agent for the radionuclide indium-111. Following an intravenous injection of Prostascint, imaging is performed using single-photon emission computed tomography (SPECT).[1]

Early trials with yttrium (90Y) capromab pendetide were also conducted.[3]

References

Шаблон:Reflist

Шаблон:Radiopharmaceuticals Шаблон:Monoclonals for tumors


Шаблон:Monoclonal-antibody-stub Шаблон:Antineoplastic-drug-stub Шаблон:Nuclear-med-stub